Umbilical Cord Processing
Currently technology does not permit expansion of HSCs, it is therefore recommended that a minimum of 80ml of blood should be collected for effective therapy.
When processing blood for future therapeutic use, every stem cell counts. To optimize safety and maximize the utility of blood, it is manually processed by our highly trained technical staff who handle the best equipment sourced from across the globe. Mycord adheres to the practice of isolating Mesenchymal stem cells from the cord tissue before storage, thereby ensuring the potency and viability of the stored cells.
Along with collection of cord blood and cord tissue, Mycord has introduced for the first time in India, technological excellence in collecting, processing and storage of the Amniotic membrane. This biological scaffold derived from the placenta has tremendous potential for skin regeneration following burns, injury and scarring.
Stringent quality control procedures are followed, for cryogenic storage in vaporized tanks for future therapeutic applications, should the need arise.